Skip to main content
$0.081 0.002 (2.53%)

High

$0.09

Low

$0.08

Trades

83

Turnover

$220,412

Volume

2,818,974
30 June 2023 at 4:10pm
If you were already registered, log in here.

ASX Announcements (7d)

-

Twitter Mentions (7d)

0+

AFR Articles (7d)

-

News Articles (7d)

2+

Short Interest

ASIC data, 14 Apr 2026

% Shorted

0.00%
vs 0.00% prior report

Most Shorted Rank

617th
of 717 shorted ASX stocks

Peak Short

0.61%
Jan 2020

Days to Cover

0.0
at 50d avg vol
Subject
PTX Ann: Application for quotation of securities - PTX

PTX Ann: Proposed issue of securities - PTX

PTX Ann: Share Purchase Plan Booklet

PTX Ann: Prescient Therapeutics Launches Share Purchase Plan

PTX Ann: Share Purchase Plan Cleansing Notice

PTX Ann: PTX Presentation

PTX Ann: Appendix 4G and Corporate Governance Statement

PTX Ann: Appendix 4E and 2022 Annual Report

PTX Ann: PTX agreement with Thermo Fisher for scalable OmniCAR

PTX Ann: PTX OmniCAR cell manufacturing contract for clinical trials

PTX Ann: June 2022 Quarterly Update and Appendix 4C

PTX Ann: Application for quotation of securities - PTX

PTX Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL

PTX Ann: Key OmniCAR Patent Granted in US

PTX Ann: Application for quotation of securities - PTX

PTX Ann: PTX CellPryme-M presentation

PTX Ann: PTX unveils new clinic-ready CAR-T enhancement platform

PTX Ann: Application for quotation of securities - PTX

PTX Ann: PTX-200 AML expansion after another complete response

PTX Ann: PTX-200 AML expansion after another complete response

PTX Ann: Prescient to Present at AVID 2022 Meeting

PTX Ann: March 2022 Quarterly Update and Appendix 4C

PTX Ann: Notification of cessation of securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Recruitment Open for Expansion Cohort of Phase 1B Study

PTX Ann: Investor Presentation

PTX Ann: Appendix 4D and Half Year Financial Report

PTX Ann: December 2021 Quarterly Update and Appendix 4C

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Section 708A Cleansing Statement

PTX Ann: PTX adds International CAR-T & Bioengineering Experts to SAB

PTX Ann: Results of Annual General Meeting

PTX Ann: AGM Presentation

PTX Ann: Chair's Address to the 2021 Annual General Meeting

PTX Ann: Notification regarding unquoted securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: September 2021 Quarterly Activities and Appendix 4C

PTX Ann: Investor Presentation - October 2021

PTX Ann: PTX data demonstrates key OmniCAR features in next gen CAR-T

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Notice of Annual General Meeting/Proxy Form

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Section 708A Cleansing Statement

PTX Ann: Notification of cessation of securities - PTX

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Section 708A Cleansing Statement

PTX Ann: Application for quotation of securities - PTX

PTX Ann: Appendix 4G and Corporate Governance Statement

PTX Ann: Appendix 4E and 2021 Annual Report

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS